DNA OLIGOMER, GENE MARKER AND DNA OLIGOMER SET FOR PREDICTING THE ONSET OF SIDE EFFECT IN RADIOTHERAPY AND METHOD OF PREDICTING THE ONSET OF SIDE EFFECT

摘要

It is intended to provide a DNA oligomer, a gene marker, a DNA oligomer set (a primer set for PCR) and a DNA oligomer (a primer for extension) whereby the risk of the onset of a side effect in a radiotherapy for cancer can be predicted by judging whether a specific base in a DNA base sequence is a risk allele or a non-risk allele; and a method of predicting the onset of a side effect in a radiotherapy. The above-described DNA oligomer for predicting the onset of a side effect in a radiotherapy has a DNA sequence having at least 10 to 241 consecutive bases including the base at the 121-position in a DNA base sequence represented by any one of SEQ ID NOS:1 to 173 in Sequence Listing.